Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic Impairment
Clinical trial NCT04573582 · COMPLETED
Trial details
- NCT number
- NCT04573582
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-13
- Primary completion
- 2023-03-08
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.